Area of research
Pulmonary and Respiratory Medicine · Surgery
Research interest
Research interests include Gastric Cancer Management and Outcomes, Esophageal Cancer Research and Treatment, Gastrointestinal Tumor Research and Treatment, and Esophageal and GI Pathology.
Comparative study of robot-assisted surgery for right-sided colon cancer: a propensity score–matched analysis of the hinotori Surgical Robot System and the da Vinci Surgical System
Propensity score–matched comparison of robot-assisted rectal cancer surgery using hinotori and da Vinci
Short-term surgical outcomes of robot-assisted colectomy for colon cancer using the hinotori Surgical Robot System
Totally laparoscopic surgery for a hydrocele of the canal of Nuck extending from the abdominal cavity to the subcutaneous space: a case report.
Successful pancreatectomy after conversion-intended chemotherapy using gemcitabine and nab-paclitaxel for unresectable adenosquamous carcinoma of the pancreas: a case report.
Robotic distal gastrectomy with left gastric artery preservation for early gastric cancer with prior splenectomy: A case report.
Muscle mass ratio in male gastric cancer patients as an independent predictor of postoperative complications after minimally invasive distal gastrectomy.
Successful treatment with laparoscopic extended posterior sectionectomy for inflammatory pseudotumor in the liver with para-aortic lymphadenitis.
The safe performance of robotic gastrectomy by second-generation surgeons meeting the operating surgeon's criteria in the Japan Society for Endoscopic Surgery guidelines.
Impact of routine preoperative sonographic screening with early intervention for deep venous thrombosis in lower extremities on preventing postoperative venous thromboembolism in patients with gastric cancer scheduled for minimally invasive surgery.
Recovery procedure for linear stapler mis-insertion in the esophageal submucosal layer during intracorporeal esophagojejunostomy.
A case of direct inguinal hernia incarceration after transperitoneal robot-assisted radical prostatectomy.
Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition